世界の認知症・運動障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1758 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、認知症・運動障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・認知症・運動障害治療の市場動向 ・企業の競争状況、市場シェア ・認知症・運動障害治療の種類別市場規模（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤） ・認知症・運動障害治療の用途別市場規模（病院、クリニック、その他） ・認知症・運動障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・認知症・運動障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・認知症・運動障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・認知症・運動障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・認知症・運動障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Novartis、Roche、Teva、Amgen、UCB、H. Lundbeck、Eli Lilly、Allergan、Eisai） ・結論

Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia.
The treatment for dementia is conducted through therapeutic approaches that provide symptomatic relief as the drugs intended for the treatment only treat the symptoms. The existing drugs in the market are unable to attack the underlying cause of the disease and prolong the treatment cost and time duration. This will in turn increase the demand for DMD since it will safely modify the progression of a disease.

Market Analysis and Insights: Global Dementia and Movement Disorder Treatment Market
The global Dementia and Movement Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dementia and Movement Disorder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dementia and Movement Disorder Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dementia and Movement Disorder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dementia and Movement Disorder Treatment market.

Global Dementia and Movement Disorder Treatment Scope and Market Size
Dementia and Movement Disorder Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dementia and Movement Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
MAO Inhibitors (Monoamine Oxidase)
AChE Inhibitors (Acetylcholinesterase)
Glutamate Inhibitors

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Roche
Teva
Amgen
UCB
H. Lundbeck
Eli Lilly
Allergan

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dementia and Movement Disorder Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 MAO Inhibitors (Monoamine Oxidase)
1.2.3 AChE Inhibitors (Acetylcholinesterase)
1.2.4 Glutamate Inhibitors
1.3 Market by Application
1.3.1 Global Dementia and Movement Disorder Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dementia and Movement Disorder Treatment Market Perspective (2016-2027)
2.2 Dementia and Movement Disorder Treatment Growth Trends by Regions
2.2.1 Dementia and Movement Disorder Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dementia and Movement Disorder Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dementia and Movement Disorder Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dementia and Movement Disorder Treatment Industry Dynamic
2.3.1 Dementia and Movement Disorder Treatment Market Trends
2.3.2 Dementia and Movement Disorder Treatment Market Drivers
2.3.3 Dementia and Movement Disorder Treatment Market Challenges
2.3.4 Dementia and Movement Disorder Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dementia and Movement Disorder Treatment Players by Revenue
3.1.1 Global Top Dementia and Movement Disorder Treatment Players by Revenue (2016-2021)
3.1.2 Global Dementia and Movement Disorder Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dementia and Movement Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dementia and Movement Disorder Treatment Revenue
3.4 Global Dementia and Movement Disorder Treatment Market Concentration Ratio
3.4.1 Global Dementia and Movement Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dementia and Movement Disorder Treatment Revenue in 2020
3.5 Dementia and Movement Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Dementia and Movement Disorder Treatment Product Solution and Service
3.7 Date of Enter into Dementia and Movement Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dementia and Movement Disorder Treatment Breakdown Data by Type
4.1 Global Dementia and Movement Disorder Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dementia and Movement Disorder Treatment Forecasted Market Size by Type (2022-2027)

5 Dementia and Movement Disorder Treatment Breakdown Data by Application
5.1 Global Dementia and Movement Disorder Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dementia and Movement Disorder Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dementia and Movement Disorder Treatment Market Size (2016-2027)
6.2 North America Dementia and Movement Disorder Treatment Market Size by Type
6.2.1 North America Dementia and Movement Disorder Treatment Market Size by Type (2016-2021)
6.2.2 North America Dementia and Movement Disorder Treatment Market Size by Type (2022-2027)
6.2.3 North America Dementia and Movement Disorder Treatment Market Size by Type (2016-2027)
6.3 North America Dementia and Movement Disorder Treatment Market Size by Application
6.3.1 North America Dementia and Movement Disorder Treatment Market Size by Application (2016-2021)
6.3.2 North America Dementia and Movement Disorder Treatment Market Size by Application (2022-2027)
6.3.3 North America Dementia and Movement Disorder Treatment Market Size by Application (2016-2027)
6.4 North America Dementia and Movement Disorder Treatment Market Size by Country
6.4.1 North America Dementia and Movement Disorder Treatment Market Size by Country (2016-2021)
6.4.2 North America Dementia and Movement Disorder Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dementia and Movement Disorder Treatment Market Size (2016-2027)
7.2 Europe Dementia and Movement Disorder Treatment Market Size by Type
7.2.1 Europe Dementia and Movement Disorder Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dementia and Movement Disorder Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dementia and Movement Disorder Treatment Market Size by Type (2016-2027)
7.3 Europe Dementia and Movement Disorder Treatment Market Size by Application
7.3.1 Europe Dementia and Movement Disorder Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dementia and Movement Disorder Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dementia and Movement Disorder Treatment Market Size by Application (2016-2027)
7.4 Europe Dementia and Movement Disorder Treatment Market Size by Country
7.4.1 Europe Dementia and Movement Disorder Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dementia and Movement Disorder Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dementia and Movement Disorder Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Type
8.2.1 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Application
8.3.1 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Region
8.4.1 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dementia and Movement Disorder Treatment Market Size (2016-2027)
9.2 Latin America Dementia and Movement Disorder Treatment Market Size by Type
9.2.1 Latin America Dementia and Movement Disorder Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dementia and Movement Disorder Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dementia and Movement Disorder Treatment Market Size by Type (2016-2027)
9.3 Latin America Dementia and Movement Disorder Treatment Market Size by Application
9.3.1 Latin America Dementia and Movement Disorder Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dementia and Movement Disorder Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dementia and Movement Disorder Treatment Market Size by Application (2016-2027)
9.4 Latin America Dementia and Movement Disorder Treatment Market Size by Country
9.4.1 Latin America Dementia and Movement Disorder Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dementia and Movement Disorder Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dementia and Movement Disorder Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Type
10.2.1 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Application
10.3.1 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country
10.4.1 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Dementia and Movement Disorder Treatment Introduction
11.1.4 Pfizer Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Dementia and Movement Disorder Treatment Introduction
11.2.4 Novartis Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Dementia and Movement Disorder Treatment Introduction
11.3.4 Roche Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Dementia and Movement Disorder Treatment Introduction
11.4.4 Teva Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.4.5 Teva Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Dementia and Movement Disorder Treatment Introduction
11.5.4 Amgen Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 UCB
11.6.1 UCB Company Details
11.6.2 UCB Business Overview
11.6.3 UCB Dementia and Movement Disorder Treatment Introduction
11.6.4 UCB Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.6.5 UCB Recent Development
11.7 H. Lundbeck
11.7.1 H. Lundbeck Company Details
11.7.2 H. Lundbeck Business Overview
11.7.3 H. Lundbeck Dementia and Movement Disorder Treatment Introduction
11.7.4 H. Lundbeck Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.7.5 H. Lundbeck Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Dementia and Movement Disorder Treatment Introduction
11.8.4 Eli Lilly Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Dementia and Movement Disorder Treatment Introduction
11.9.4 Allergan Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.9.5 Allergan Recent Development
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Dementia and Movement Disorder Treatment Introduction
11.10.4 Eisai Revenue in Dementia and Movement Disorder Treatment Business (2016-2021)
11.10.5 Eisai Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dementia and Movement Disorder Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of MAO Inhibitors (Monoamine Oxidase)
Table 3. Key Players of AChE Inhibitors (Acetylcholinesterase)
Table 4. Key Players of Glutamate Inhibitors
Table 5. Global Dementia and Movement Disorder Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dementia and Movement Disorder Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dementia and Movement Disorder Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Dementia and Movement Disorder Treatment Market Share by Regions (2016-2021)
Table 9. Global Dementia and Movement Disorder Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Dementia and Movement Disorder Treatment Market Share by Regions (2022-2027)
Table 11. Dementia and Movement Disorder Treatment Market Trends
Table 12. Dementia and Movement Disorder Treatment Market Drivers
Table 13. Dementia and Movement Disorder Treatment Market Challenges
Table 14. Dementia and Movement Disorder Treatment Market Restraints
Table 15. Global Dementia and Movement Disorder Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Dementia and Movement Disorder Treatment Market Share by Players (2016-2021)
Table 17. Global Top Dementia and Movement Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia and Movement Disorder Treatment as of 2020)
Table 18. Ranking of Global Top Dementia and Movement Disorder Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Dementia and Movement Disorder Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dementia and Movement Disorder Treatment Product Solution and Service
Table 22. Date of Enter into Dementia and Movement Disorder Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dementia and Movement Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Dementia and Movement Disorder Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Dementia and Movement Disorder Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Dementia and Movement Disorder Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Dementia and Movement Disorder Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Dementia and Movement Disorder Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Dementia and Movement Disorder Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Dementia and Movement Disorder Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Dementia and Movement Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Dementia and Movement Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Dementia and Movement Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Dementia and Movement Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Dementia and Movement Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Dementia and Movement Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Dementia and Movement Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Dementia and Movement Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Dementia and Movement Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Dementia and Movement Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Dementia and Movement Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Dementia and Movement Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Dementia and Movement Disorder Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Dementia and Movement Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Dementia and Movement Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Dementia and Movement Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Dementia and Movement Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Dementia and Movement Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Dementia and Movement Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Dementia and Movement Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Dementia and Movement Disorder Treatment Product
Table 65. Pfizer Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Dementia and Movement Disorder Treatment Product
Table 70. Novartis Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Dementia and Movement Disorder Treatment Product
Table 75. Roche Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Teva Company Details
Table 78. Teva Business Overview
Table 79. Teva Dementia and Movement Disorder Treatment Product
Table 80. Teva Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 81. Teva Recent Development
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Dementia and Movement Disorder Treatment Product
Table 85. Amgen Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 86. Amgen Recent Development
Table 87. UCB Company Details
Table 88. UCB Business Overview
Table 89. UCB Dementia and Movement Disorder Treatment Product
Table 90. UCB Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 91. UCB Recent Development
Table 92. H. Lundbeck Company Details
Table 93. H. Lundbeck Business Overview
Table 94. H. Lundbeck Dementia and Movement Disorder Treatment Product
Table 95. H. Lundbeck Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 96. H. Lundbeck Recent Development
Table 97. Eli Lilly Company Details
Table 98. Eli Lilly Business Overview
Table 99. Eli Lilly Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 100. Eli Lilly Recent Development
Table 101. Allergan Company Details
Table 102. Allergan Business Overview
Table 103. Allergan Dementia and Movement Disorder Treatment Product
Table 104. Allergan Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 105. Allergan Recent Development
Table 106. Eisai Company Details
Table 107. Eisai Business Overview
Table 108. Eisai Dementia and Movement Disorder Treatment Product
Table 109. Eisai Revenue in Dementia and Movement Disorder Treatment Business (2016-2021) & (US$ Million)
Table 110. Eisai Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dementia and Movement Disorder Treatment Market Share by Type: 2020 VS 2027
Figure 2. MAO Inhibitors (Monoamine Oxidase) Features
Figure 3. AChE Inhibitors (Acetylcholinesterase) Features
Figure 4. Glutamate Inhibitors Features
Figure 5. Global Dementia and Movement Disorder Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Dementia and Movement Disorder Treatment Report Years Considered
Figure 10. Global Dementia and Movement Disorder Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Dementia and Movement Disorder Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dementia and Movement Disorder Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Dementia and Movement Disorder Treatment Market Share by Regions (2022-2027)
Figure 14. Global Dementia and Movement Disorder Treatment Market Share by Players in 2020
Figure 15. Global Top Dementia and Movement Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dementia and Movement Disorder Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Dementia and Movement Disorder Treatment Revenue in 2020
Figure 17. Global Dementia and Movement Disorder Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Dementia and Movement Disorder Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Dementia and Movement Disorder Treatment Market Share by Type (2016-2027)
Figure 21. North America Dementia and Movement Disorder Treatment Market Share by Application (2016-2027)
Figure 22. North America Dementia and Movement Disorder Treatment Market Share by Country (2016-2027)
Figure 23. United States Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dementia and Movement Disorder Treatment Market Share by Type (2016-2027)
Figure 27. Europe Dementia and Movement Disorder Treatment Market Share by Application (2016-2027)
Figure 28. Europe Dementia and Movement Disorder Treatment Market Share by Country (2016-2027)
Figure 29. Germany Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dementia and Movement Disorder Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Dementia and Movement Disorder Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Dementia and Movement Disorder Treatment Market Share by Region (2016-2027)
Figure 39. China Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dementia and Movement Disorder Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Dementia and Movement Disorder Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Dementia and Movement Disorder Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dementia and Movement Disorder Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Dementia and Movement Disorder Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Dementia and Movement Disorder Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Dementia and Movement Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 61. Teva Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 63. UCB Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 64. H. Lundbeck Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 66. Allergan Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 67. Eisai Revenue Growth Rate in Dementia and Movement Disorder Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---